Open AccessAn acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
Author(s) -
Gupta Katharine,
Estrella Jane,
Rajagopal Rohit,
Shanmugalingam Praseetha,
Simmons David
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1022
Subject(s) - medicine , bisphosphonate , disease , graves' disease , intensive care medicine , osteoporosis
Key Clinical Message Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves’ thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy.